Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
5,11 USD | -8,09 % | -7,59 % | -34,40 % |
Resumen de negocios
Número de empleados: 68
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Gene Control Medicines
100,0
%
| 15 | 100,0 % | 10 | 100,0 % | -33,23 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 15 | 100,0 % | 10 | 100,0 % | -33,23 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Conley Chee
CEO | Chief Executive Officer | 54 | 27/09/21 |
Nancy Simonian
CEO | Chief Executive Officer | 63 | 01/11/12 |
Jason Haas
DFI | Director of Finance/CFO | 56 | 12/10/21 |
David Roth
CTO | Chief Tech/Sci/R&D Officer | 61 | 07/12/15 |
Gerald Quirk
ADM | Chief Administrative Officer | 56 | 01/09/16 |
Karen Hunady
IRC | Investor Relations Contact | - | 01/10/22 |
Lisa Roberts
HRO | Human Resources Officer | - | 01/01/12 |
Kristin Stephens
PRN | Corporate Officer/Principal | 51 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Srini Akkaraju
BRD | Director/Board Member | 56 | 12/06/17 |
Tim Tyson
BRD | Director/Board Member | 71 | 16/09/22 |
Marsha Fanucci
BRD | Director/Board Member | 70 | 19/10/15 |
Deborah Dunsire
BRD | Director/Board Member | 61 | 09/09/21 |
Peter Wirth
CHM | Chairman | 73 | 30/01/17 |
Nancy Simonian
CEO | Chief Executive Officer | 63 | 01/11/12 |
Richard Young
FOU | Founder | 70 | 09/11/11 |
S. Gail Eckhardt
BRD | Director/Board Member | 66 | 08/09/20 |
Andrew Oh
BRD | Director/Board Member | 53 | 16/09/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 26 453 891 | 26 167 872 ( 98,92 %) | 0 | 98,92 % |
Información de la empresa
Syros Pharmaceuticals, Inc.
35 CambridgePark Drive 4th floor
02140-2325, Cambridge
+617 744 1340
http://www.syros.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-34,40 % | 135 M | |
-1,78 % | 41,36 mil M | |
+44,81 % | 41,3 mil M | |
+4,01 % | 39,61 mil M | |
-15,14 % | 25,62 mil M | |
+3,16 % | 24,09 mil M | |
-24,08 % | 18,38 mil M | |
-2,67 % | 11,82 mil M | |
+24,76 % | 11,85 mil M | |
+7,01 % | 11,07 mil M |
- Bolsa de valores
- Acciones
- Acción SYRS
- Empresa Syros Pharmaceuticals, Inc.